NewsRoom Articles - Page 204 of 252

MondayMar 12, 2018 4:13 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Linker Tech Mimics Body’s Production of Pain Relieving Peptides

Developing pain relievers that mimic body’s natural pain relief peptides Other programs include development of treatments for diabetes, synthetization of blue scorpion venom and study of a novel cannabinoid delivery platform Revenues from international licensing strategy The discovery of endomorphins in 1997 was a remarkable reminder of the human body’s wondrous nature. Endomorphins are naturally produced morphine-like substances with an affinity for the µ-opioid receptors in the brain, which fortunately happen to be the best places to alleviate pain. With a potency that far exceeds morphine, these endogenous substances are the body’s first line of defense against pain and stress.…

MondayMar 12, 2018 2:58 pm

Global Payout Inc. (GOHE) has Many Fingers in the Fintech Pie

Global Reserve Platform offers ‘Banking-in-a-Box’ web-based technology Capability to provide a wide range of financial product solutions Strategic focus on freight forwarding and shipping In the 16th century, the Belgian city of Antwerp, enthused by the entrepreneurial spirit of its burghers, became ‘the center of the entire international economy’. That innovative force made the city the diamond capital of the globe and the location of the world’s oldest stock exchange building, which is in operation to this day. The port of Antwerp, one of the largest in the world, is testing a blockchain system designed to make the handling of containers more…

MondayMar 12, 2018 11:48 am

Pressure BioSciences’ (PBIO) Patented Tech Enhances Nanoemulsion Bioavailability and Extends Product Shelf Life

Patented UST process produces highly stable, clean and cost-effective nanoemulsions Technology can be applied across many industries, including pharmaceutical, food, nutraceutical, industrial lubricant, paint and cosmetic sectors UST technology aligns with consumer demand for chemical- and preservative-free products The demand for nanoemulsions is growing at a fast pace, with potential applications in many industry sectors, including food, pharmaceuticals, nutraceuticals, cosmetics and industrial lubricants. Up to now, one of the major problems with nanoemulsions has been their instability. This instability compromises the bioavailability and absorption of active ingredients for product preparation and the shelf life of the product. Life sciences company…

FridayMar 09, 2018 3:02 pm

ChineseInvestors.com, Inc. (CIIX) Turns Focus to Growth of Cryptocurrency and Blockchain Technology, Financial Consulting Division

Company returning to its roots in financial consulting, corporate brand building and educational services for cryptocurrencies, such as bitcoin CIIX has daily video from NYSE targeted at its global Chinese-speaking investment community titled ‘Bitcoin MultiMillionaire’ and hosts a bitcoin ATM in the lobby of its San Gabriel, California, headquarters Company is urging its shareholders to convert stock, on a four-for-one basis, for a share in the new, private company that includes hemp assets CBD Biotechnology Co. Ltd., Hemp Logic, Inc. and ChineseHempOil.com, Inc. ChineseInvestors.com, Inc. (OTCQB: CIIX) will return to its roots as a financial consultant and a specialist in…

FridayMar 09, 2018 2:15 pm

Earth Science Tech, Inc. (ETST) Enlarges Its Footprint in Hemp-Based CBD Market

Agreement with Mr. Checkout will significantly strengthen the company’s product distribution network Human trials launched evaluating CBD-based therapy for opioid addiction Application made to uplist to OTCQB in early 2018, attracting more investment The worldwide cannabidiol (CBD) oil market, which includes products derived from both marijuana and hemp, is projected to grow at a CAGR of more than 39 percent through 2021. The health benefits of CBD oil are the major driver for growth in this market, with global demand steadily on the rise in recent years. Hemp-based CBD oil products in particular are more popular, as they have a…

ThursdayMar 08, 2018 4:00 pm

Building a Portfolio of Industrial Hemp Companies is Key to the Future of Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF)

Global Hemp Group will employ joint ventures, partnerships, and acquisitions to capture cash flow, generate revenues and create value for its shareholders Global Hemp Group will be involved in the cultivation, processing and distribution of industrial hemp to domestic and international markets At the end of 2017, GHG issued its final report on the first year of its joint venture to produce industrial hemp on the Arcadian Peninsula of New Brunswick, Canada Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is focused on the vital role that industrial hemp will play in building a sustainable future. The company…

ThursdayMar 08, 2018 9:00 am

Acquisitions and Growth Expand in Canadian Cannabis Market

CBDWire Editorial Coverage: The first wave of companies to enter the Canadian cannabis industry were grounded in medical marijuana, which was legalized in 2001. As the country prepares for legalized adult recreational-use this summer, new recreational brands are joining the scene, and many companies rooted in medicinal cannabis are taking action to participate in this second wave of the Canadian market. With its strong branding and modern store design, Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF) (CHOOF Profile) is branded to appeal to the Canadian adult consumer ready to experience the cannabis lifestyle. Aurora Cannabis, Inc. (TSX: ACB) (OTCQB: ACBFF)…

WednesdayMar 07, 2018 3:49 pm

Medical Cannabis Payment Solutions (REFG) in Marathon Drive to Serve Marijuana Customers with Unique Platform

‘Green’ payment system offers security and regulatory transparency Expanding legalization efforts mean more opportunity in market that’s expected to exceed $31 billion within the next three years Company working out cryptocurrency alternative to U.S. dollar financing In late February, a federal judge issued the latest legal finding on the drive to overturn the U.S. government’s classification of marijuana as an illegal drug, delivering a ruling that rejected medical marijuana patients’ claims that the ban is an unconstitutional violation of their rights (http://cnw.fm/DaqG1). The decision, based on a procedural finding that the plaintiffs had not gone through proper procedures with the…

WednesdayMar 07, 2018 3:08 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Licensing Agreement with Cannabis Edibles Infusion Manufacturer

Lexaria enters agreement with Biolog for Lexaria’s DehydraTECH™ technology in return for royalties on sales revenue and licensing fees Biolog has exclusive rights to use the Lexaria technology for its particular applications for five years Lexaria is the only company worldwide with patent issued for oral delivery CBD and all other non-psychoactive cannabinoids Based in Kelowna, British Columbia, Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced on February 27, 2018, its entry into a technology licensing agreement with Biolog, Inc. for the provision of Lexaria’s patented DehydraTECH™ technology (http://cnw.fm/pY0oG). Lexaria’s proprietary technology will be used in the formulation of a…

WednesdayMar 07, 2018 1:21 pm

Cronos Group Inc. (NASDAQ: CRON) (TSX.V: MJN) is Building an International Brand Portfolio

Leading the industry forward as the first pure-play cannabis company to trade on the Nasdaq Canada set to legalize recreational cannabis Positioned for growth throughout the international medical marijuana market Cronos Group Inc. (NASDAQ: CRON) (TSX.V: MJN), a Toronto-based medical marijuana company, is the first pure-play cannabis company to trade on the Nasdaq. This transition has provided the company with legitimacy and enables investors to better assess CRON’s performance. Listing of CRON on the Nasdaq is a major move for the entire marijuana industry, according to The Motley Fool (http://cnw.fm/jL0b9). With cannabis deals this year already doubling the total for…

News and publishing service for CBD related companies

Contact us: 303.498.7722